SCHEMBL6002568

SCHEMBL6002568

O=[C]N(OC(F)(F)C(F)(F)C(F)(F)F)c1ccccc1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002629 0.71 NPSR1 (0.34) TACR1
SCHEMBL6002979 0.69 ELANE (0.32)
SCHEMBL6002564 0.68 ATM (0.33) TACR1
SCHEMBL1335024 0.67 KMT2A (0.38)
SCHEMBL4634276 0.67 ALDH1A1 (0.38)
SCHEMBL621536 0.66 L3MBTL1 (0.39)
SCHEMBL11036085 0.65 CYP2C9 (0.33)
SCHEMBL31723993 0.63 NR1H3 (0.46)
SCHEMBL3486119 0.63 CES1 (0.37)
SCHEMBL9033853 0.63 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed